Stock listing
OTC:GBLX GB Sciences, Inc. Stock
Follow GB Sciences, Inc. into a list and get an email when it puts out news.
Share price · OTC:GBLX
$0.0002 USD +0.0001 (+100.0%)
Close on Nov 20, 2026
- Day range
- $0.0001 – $0.0002 USDNov 20, 2026
- Volume
- 3,800 sharesNov 20, 2026
- Market cap
- $81,414 USDAt the close on Nov 20, 2026 · price × 407.1M shares outstanding
- 52-week range
- $0.0001 – $0.5002 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $7 USDMedian day 14,105 shares · 6 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:GBLX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0002 | +0.0001 | +100.0% | $0.0001 | $0.0002 | $0.0001 | 3,800 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 93,654 | |
| $0.0001 | -0.0001 | -50.0% | $0.0002 | $0.0002 | $0.0001 | 1,083,165 | |
| $0.0002 | +0.0001 | +100.0% | $0.0001 | $0.0002 | $0.0001 | 2,100 | |
| $0.0001 | -0.0001 | -50.0% | $0.0001 | $0.0002 | $0.0001 | 65,459 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 1,993 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 130,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 15,973 | |
| $0.0002 | +0.0001 | +100.0% | $0.0001 | $0.0002 | $0.0001 | 2,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 8,113 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 39,566 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 43,250 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 16,340 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 2,056 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 25,500 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 500 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 4,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 24,901 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 1,800 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 1,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 21,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 6,125 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 1,245 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 14,350 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 16,565 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 750 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 17,300 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 19,405 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 18,398 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 7,325 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 13,860 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 17,483 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0015 | $0.0001 | 108,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 950 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 378,393 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 1,400 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0002 | $0.0001 | 151,721 | |
| $0.0001 | -0.0001 | -50.0% | $0.0001 | $0.0002 | $0.0001 | 1,169 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 500 | |
| $0.0002 | +0.0001 | +100.0% | $0.0002 | $0.0002 | $0.0002 | 4,145 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 2,732 | |
| $0.0001 | -0.0001 | -50.0% | $0.0001 | $0.0002 | $0.0001 | 96,103 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 78,500 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 46,746 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 27,971 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 3,500 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0016 | $0.0002 | 12,881 | |
| $0.0002 | -0.0001 | -33.3% | $0.0002 | $0.0003 | $0.0002 | 31,665 | |
| $0.0003 | 0.0000 | 0.0% | $0.0001 | $0.0003 | $0.0001 | 35,992 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 27,542 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 20,401 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 62,600 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 275,761 | |
| $0.0003 | -0.0001 | -25.0% | $0.0003 | $0.0003 | $0.0003 | 71,200 | |
| $0.0004 | +0.0001 | +33.3% | $0.0003 | $0.0004 | $0.0003 | 1,600 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 2,600 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 70,000 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 2,018 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 500 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 17,011 |
Splits
3 splits since 2004 · OTC:GBLX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation | |
| 1-for-50 | Consolidation | |
| 5-for-1 | Split |
- Ticker
- OTC:GBLX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Latest news
GB Sciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 143 in all · newest Dec 22, 2022 · oldest 2017
- Decks
- 4 decks · latest August 2024
Valuation
balance Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- $2.07M USD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- -0.46
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| GB Sciences, Inc. · OTC:GBLX | US$81,414 | US$2.07M | n/a | n/a | n/a | n/a | n/a | n/a | -0.46 |
| NKGen Biotech Inc. · OTC:NKGN | US$391,807 | US$38.58M | n/a | n/a | n/a | n/a | n/a | n/a | 0.88 |
| Vaxil Bio Ltd. · TSXV:VXL | US$319,522 | −US$4,071 | 1.2× | n/a | n/a | 0.4× | n/a | 0.0× | -0.16 |
| Chimeric Therapeutics Limited · ASX:CHM | US$292,816 | −US$220,193 | n/a | −0.1× | n/a | 0.2× | −262.8% | 2.5× | n/a |
| CERo Therapeutics Holdings, Inc. · OTC:CERO | US$265,035 | −US$190,890 | n/a | n/a | n/a | n/a | n/a | n/a | 1.47 |
| CDT Equity Inc. · NASDAQ:CDT | US$234,109 | −US$1.49M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.14 |
| GlucoTrack, Inc. · NASDAQ:GCTK | US$217,049 | −US$887,951 | n/a | n/a | n/a | n/a | n/a | n/a | 1.73 |
| Regen BioPharma, Inc. · OTC:RGBP | US$167,528 | US$167,289 | n/a | 0.7× | n/a | n/a | −501.4% | n/a | 1.20 |
| CNBX Pharmaceuticals Inc. · OTC:CNBX | US$160,577 | US$151,090 | n/a | n/a | n/a | n/a | n/a | n/a | 1.78 |
| Fifty 1 Labs Inc. · OTC:FITY | US$118,532 | US$282,021 | n/a | 6,000× | n/a | n/a | n/a | n/a | -1.17 |
| Lyra Therapeutics, Inc. · OTC:LYRA | US$53,246 | US$14.42M | n/a | 36.2× | n/a | n/a | n/a | n/a | 0.67 |
| Median of the others | US$225,579 | US$73,510 | 1.2× | 18.5× | 0.2× | −382.1% | 0.0× | 1.14 |
Team and board
Officers
| Officer | Role |
|---|---|
| Andrea Small-Howard | Chairman of the Scientific Advisory Board, Chief Science Officer and Director |
Board
| Director | Role |
|---|---|
| Andrea Small-Howard | Chairman of the Scientific Advisory Board, Chief Science Officer and Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | Aug 12, 2025 | +200.0% |
| Q2 2025 | Nov 18, 2024 · After close | |
| Q3 2024 | Feb 12, 2024 · After close | +1.8% |
| Q2 2024 | Nov 20, 2023 · After close | −11.4% |
| Q1 2024 | Aug 14, 2023 · After close | +3.5% |
| Q3 2023 | Feb 3, 2023 · After close | −1.4% |
| Q2 2023 | Nov 9, 2022 · After close | −3.6% |
| Q1 2023 | Aug 11, 2022 · After close | +5.9% |
| Q4 2022 | Jun 30, 2022 | −14.4% |
| Q3 2022 | Feb 11, 2022 | −5.9% |
All 14 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2022 | Nov 15, 2021 | −7.8% |
| Q1 2022 | Jul 6, 2021 | −10.3% |
| Q4 2021 | Jun 30, 2021 | −10.0% |
| Q3 2021 | Feb 16, 2021 | +25.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2024) | Investor deck | 15 slides | August 2024 |
| Investor Presentation (March 2018) | Investor deck | 16 slides | Mar 19, 2018 |
| Investor Presentation (March 2018) | Investor deck | 16 slides | Mar 16, 2018 |
| Investor Presentation (March 2018) | Investor deck | 19 slides | Mar 12, 2018 |
Financials
Annual, in USD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 3.12M | 3.12M | 3.46M | 2.51M | 0 | 0 | 0 |
| Cost of revenue | 624 | 61.7K | 70.5K | 47.4K | 4.00M | 3.25M | 782.7K | 416.0K | 177.1K | 70.0K |
| Gross profit | -624 | -61.7K | -70.5K | -47.4K | -126.0K | 208.5K | 1.73M | -416.0K | -177.0K | 0 |
| Research and development | 261.6K | 490.3K | 821.3K | 352 | 1.54K | 458.8K | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 1.16M | 1.67M | 1.87M | 2.00M | 5.68M | 13.4M | 19.6M | 8.93M | 6.96M | 7.97M |
| Operating income | -1.42M | -1.67M | -1.87M | -2.00M | -12.0M | -13.2M | -17.8M | -8.93M | -6.96M | -7.97M |
| Depreciation and amortization | 624 | 61.7K | 70.5K | 47.4K | 258.7K | 250.2K | 804.8K | 416.0K | 177.1K | 69.1K |
| EBITDA | -1.42M | -1.61M | -1.80M | -1.95M | -11.8M | -12.9M | -17.0M | -8.52M | -6.78M | -7.90M |
| Interest expense | 219.0K | 178.7K | 474.8K | 1.28M | 1.63M | 4.94M | 5.18M | 901.1K | 105.2K | 230 |
| Income before tax | -1.36M | -4.13M | -147.0K | -3.33M | -4.75M | -21.5M | -23.2M | -10.1M | -7.08M | -7.97M |
| Income tax | 278.3B | 2.63T | -1.80M | 1.45M | 86.8K | 526.1K | 4.83M | 727.9K | -202.0K | -250.7K |
| Net income | -1.36M | -4.13M | -531.0K | -3.73M | -12.4M | -23.7M | -23.0M | -9.91M | -6.77M | -7.72M |
| Earnings per share, basic | -0.00 | -0.01 | -0.00 | -0.01 | -0.05 | -0.11 | -0.17 | -0.13 | -0.15 | -0.26 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12.0K | 109.9K | 233.9K | 793.0K | 151.8K | 227.8K | 3.58M | 2.69M | 34.8K | 0 |
| Short-term investments | 0 | 0 | 0 | 0 | 0 | |||||
| Receivables | 5.34M | 488.3K | 667.1K | 0 | 67.9K | 50.0K | ||||
| Inventory | 1.45M | 2.14M | 1.05M | 89.0K | 0 | 0 | ||||
| Current assets | 103.4K | 309.5K | 327.8K | 3.54M | 7.00M | 3.47M | 7.25M | 2.95M | 207.5K | 240.4K |
| Property, plant and equipment | 25.0K | 37.8K | 10.5M | 13.8M | 8.64M | 1.95M | 913.6K | |||
| Goodwill | -42.8B | -2.22T | -1.71T | -1.70T | -1.82T | 1.40M | 0 | 0 | 0 | |
| Total assets | 103.4K | 352.3K | 2.55M | 10.8M | 14.4M | 30.0M | 24.0M | 13.0M | 2.44M | 1.45M |
| Accounts payable | 2.01M | 1.98M | 1.66M | 1.41M | 1.32M | 1.37M | 371.9K | 176.2K | 902.1K | 677.2K |
| Current liabilities | 5.10M | 4.76M | 3.94M | 8.60M | 10.9M | 6.71M | 1.92M | 675.6K | 2.26M | 984.6K |
| Long-term debt | 322.0K | 397.3K | 292.4K | 161.1K | 355.2K | 155.3K | 2.15M | 0 | ||
| Total debt | 1.76M | 1.40M | 1.38M | 4.46M | 9.42M | 8.68M | 7.55M | 3.93M | 2.61M | 30.0K |
| Total liabilities | 5.42M | 4.76M | 4.33M | 12.3M | 14.4M | 12.9M | 8.42M | 4.60M | 4.41M | 1.21M |
| Shareholders' equity | -5.31M | -4.41M | -1.78M | -1.47M | -88.5K | 8.30M | 12.7M | 8.33M | -1.90M | 497.3K |
| Shares outstanding | 396.7M | 357.7M | 317.6M | 285.2M | 258.5M | 209.5M | 132.9M | 79.0M | 44.9M | 29.5M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -975.7K | -1.53M | -1.87M | -2.19M | -4.48M | -9.24M | -12.2M | -4.47M | -3.56M | -3.55M |
| Capital spending | -2 | -31.6K | -200.0K | -292.7K | -294.2K | -10.6M | -3.43M | -3.05M | -881.6K | -937.7K |
| Free cash flow | -975.7K | -1.56M | -2.07M | -2.48M | -4.77M | -19.8M | -15.7M | -7.52M | -4.45M | -4.48M |
| Cash from investing | 320.0K | -31.6K | 1.45M | 4.66M | -538.8K | -11.6M | -5.40M | -4.20M | -859.1K | -662.7K |
| Cash from financing | 557.8K | 1.43M | -495.9K | -1.48M | 4.99M | 17.5M | 18.5M | 11.3M | 4.46M | 3.87M |
| Dividends paid | -2.86T | 0 | 0 | 0 | 0 | |||||
| Share buybacks | 968.0K | -809.2K | 0 | 0 | 0 | 0 | ||||
| Change in cash | -97.9K | -124.0K | -911.7K | 641.3K | -30.3K | -3.35M | 886.7K | 2.66M | 34.8K | 3.87M |
Cap table
Built by 6ix from GB Sciences, Inc.’s releases
- Common shares
- 407,071,028
- Fully diluted
- 407,071,028
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 407,071,028 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 407,071,028 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Craig Ellins Other companies: One World Pharma, Inc. (CEO and CFO, Director · Mar 3, 2020 – Mar 3, 2020 · Past) | CEO, Director · Mar 2, 2017 – Jun 16, 2017 · Past |
| John C Poss | Chief Executive Officer, Director · Jul 11, 2018 – Jul 27, 2018 · Past |
Log in to ask 6ix AI your own questions about GB Sciences, Inc.